JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lorberboym, M.
Right arrow Articles by Sadeh, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lorberboym, M.
Right arrow Articles by Sadeh, M.
Journal of Nuclear Medicine Vol. 44 No. 12 1898-1904
© 2003 by Society of Nuclear Medicine


Clinical Investigations

Correlation of 99mTc-DTPA SPECT of the Blood–Brain Barrier with Neurologic Outcome After Acute Stroke

Mordechai Lorberboym, MD1, Yair Lampl, MD2 and Menahem Sadeh, MD2

1 Department of Nuclear Medicine, Sackler Faculty of Medicine, Edith Wolfson Medical Center, Tel Aviv University, Tel Aviv, Israel
2 Department of Neurology, Sackler Faculty of Medicine, Edith Wolfson Medical Center, Tel Aviv University, Tel Aviv, Israel

We conducted a study on humans to determine whether quantitative evaluation of blood–brain barrier (BBB) breakdown using the 99mTc-diethylenetriaminepentaacetic acid (99mTc-DTPA) SPECT technique at the peak time of stroke evolution can predict neurologic outcome. Methods: Thirty consecutive patients with acute stroke of the middle cerebral artery occurring >24 h and <48 h before admission were included in the study. Each patient underwent a complete neurologic examination according to the Scandinavian stroke score at 72 h after the stroke (S1) and again at 30 d (S2). The difference between initial and late scores was calculated ({Delta} S) and used to evaluate the change in neurologic status. A CT scan was obtained on all patients to determine the volume of stroke. The integrity of the BBB was evaluated using 99mTc-DTPA brain SPECT. A quantitative index of BBB disruption was defined as the ratio of the mean counts/pixel in the infarcted region compared with the mean counts/pixel in the contralateral nonaffected hemisphere. SPECT perfusion imaging was also performed with 99mTc-hexamethylpropyleneamine oxime (99mTc-HMPAO) at 24 h after the 99mTc-DTPA study. The relative perfusion in the infarct region was expressed as the percentage of contralateral perfusion. Results: The mean 99mTc-DTPA disruption index was 6.8 ± 6.9 (range, 1–26.2). Seven patients (23%) had no BBB disruption. Statistical analysis showed that the disruption index was negatively correlated with {Delta} S (r = -0.423, P < 0.02). A disruption index of <2.5 was associated with a significantly better neurologic outcome (mean {Delta} S, 17.5 ± 9.5) compared with patients with an index of >2.5 (mean {Delta} S, -0.85 ± 4.97, P < 0.0001) with a sensitivity of 95% and a specificity of 89%. S2 was significantly correlated with S1 (r = 0.738, P < 0.001) and with {Delta} S (r = 0.656, P < 0.001). Perfusion abnormalities on the 99mTc-HMPAO SPECT studies ranged between 12% and 90% (mean, 37.6% ± 17.8%) compared with those on the contralateral nonaffected side. No correlation was found between 99mTc-HMPAO uptake and {Delta} S, infarct volume by CT, or disruption index. The CT volume measurements were negatively correlated with S2 (r = -0.560, P < 0.004) but not with {Delta} S. Conclusion: 99mTc-DTPA SPECT of the BBB combined with quantitative analysis in patients with acute stroke is significantly related to clinical outcome, with a distinct prognostic cutoff threshold of 2.5. The use of this radionuclide brain SPECT technique represents a unique application of conventional nondiffusible brain agents.

Key Words: stroke • blood–brain barrier • 99mTc-DTPA • 99mTc-HMPAO • SPECT




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
A.A. Konstas, G.V. Goldmakher, T.-Y. Lee, and M.H. Lev
Theoretic Basis and Technical Implementations of CT Perfusion in Acute Ischemic Stroke, Part 2: Technical Implementations
AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 885 - 892.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Ishikawa, T. Vowinkel, K. Y. Stokes, T. V. Arumugam, G. Yilmaz, A. Nanda, and D. N. Granger
CD40/CD40 Ligand Signaling in Mouse Cerebral Microvasculature After Focal Ischemia/Reperfusion
Circulation, April 5, 2005; 111(13): 1690 - 1696.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.